本次大會按照慣例仍將舉辦青年英文優(yōu)秀論文演講比賽，包括英語國家的學(xué)術(shù)演講比賽和非英語國家的學(xué)術(shù)演講比賽，獲勝者將獲得第28屆IUA世界大會的獎品和證書；其中我國青年學(xué)者前2名將全額資助參加2019年7月在捷克首都布拉格舉辦的國際血管聯(lián)盟青年講習(xí)班，前5名將全額資助參加2019年5月在北京舉辦的國際血管聯(lián)盟青年專家腔內(nèi)介入技術(shù)培訓(xùn)班。歡迎優(yōu)秀的青年學(xué)者積極參與。
我們在過去十多年里成功舉辦了十三屆中國首都血管論壇（Chinese Capital Vascular Symposium, CCVS），對推動我國血管疾病的診斷與治療技術(shù)的創(chuàng)新起到了很大的促進(jìn)作用。而目前血管疾病診療的各種新技術(shù)飛速發(fā)展，為我國血管疾病的治療起到了非常好的促進(jìn)作用。我們采用專題討論形式的學(xué)術(shù)交流，促進(jìn)了我國血管外科學(xué)術(shù)水平的提高，明顯縮小了我國與國外的差距。因此我們決定繼續(xù)舉辦"第十四屆中國首都血管論壇（CCVS）"。
下肢血管疾病學(xué)術(shù)論壇從2005年開始已經(jīng)成功舉辦了十屆，今年我們將同期舉辦第十一屆下肢血管疾病學(xué)術(shù)論壇。
歡迎各位血管方面的專家積極參與，為我國血管事業(yè)的發(fā)展做出應(yīng)有的貢獻(xiàn)。
基本信息
會議日期：
2018年10月18日—21日
會議地點：
北京國際會議中心
地址：中國北京北辰東路8號 郵編100101
報到時間：
2018年10月18日全天 08:00開始（請詳看日程安排）
報到地點:
北京市北辰東路8號，北京國際會議中心一樓注冊區(qū)。
大會官方語言：英語（同聲傳譯），中文
大會官方網(wǎng)站
http://iua2018.medmeeting.org
主辦單位：
國際血管聯(lián)盟
中國產(chǎn)學(xué)研合作促進(jìn)會
承辦單位：
中關(guān)村精準(zhǔn)醫(yī)學(xué)基金會
北京華炎血管疾病診療產(chǎn)業(yè)技術(shù)創(chuàng)新戰(zhàn)略聯(lián)盟
首都醫(yī)科大學(xué)宣武醫(yī)院
協(xié)辦單位：
中國醫(yī)藥衛(wèi)生事業(yè)發(fā)展基金會
全國衛(wèi)生產(chǎn)業(yè)企業(yè)管理協(xié)會
首都醫(yī)科大學(xué)血管外科研究所
日程安排（初擬）
部分講座主題:
1. Ultrasound, atherosclerotic plaques and risk prediction------Andrew Nicolaides(Cyprus)
2. Enabling long term implantation of vascular devices------Alan Dardik（USA）
3. Critical aspect of contemporary management of venous malformation: Coagulation Issue. --------BB Lee (USA)
4. Conceptual approach to the Venous Malformation management. -------- BB Lee (USA)
5. Invasive therapies for varicose veins: different techniques in comparison----Claudio ALLEGRA(Italy)
6. Stem cell therapy in PAOD--- Dong-ik Kim(Korea)
7. Recanalization rates after re-use of RFA fibre treatment of varicose veins----Edwin Stephen (India)
8. Experience with management of thoracic outlet syndrome----Edwin Stephen (India)
9. Venotonic drugs in vascular indications-----EviKalodiki (UK)
10. The venous puzzle: from hemodynamics to chronic disease to DVT. The pieces are coming together---Fedor Lurie (USA)
11. Topic of the arterial endofibrosis-------FEUGIER Patrick(France)
12. Advances with TEVAR intervention for treatment of type B aortic dissection-----Frank J Criado（USA）
13. Risk factors for developing peripheral artery disease in low and middle-income countries---- Gerry Fowkes(UK)
14. Workup for the patients with FMD------Heather Gornik(USA)
15. What is optimal medical therapy for PAD to date? ------ Heather Gornik(USA)
16. How to best choose between chimney and fenestrated strategies for short neck AAA---Jason Lee（USA）
17. Arch chimney repair for thoracic pathology------Jason Lee（USA）
18. An update on the use of conventional and newer anticoagulants in vascular medicine and surgery. ----- Jawed Fareed(USA)
19. Pathogenesis of CVD and its management--- Jawed Fareed(USA)
20. The future of heparins, aspirin and warfarin in coming years---- Jawed Fareed(USA)
21. Interphase between inflammation and vascular disorders------ Jawed Fareed(USA)
22. Development of a new small calibre prosthetic vascular graft-----John Fletcher（Australia）
23. Can Pre-clinical models challenge the current treatment of DVT? ------Jose Diaz（USA）
24. Current evidence in dual antiplatelet for anticoagulated patients------Jorge Saucedo(USA)
25. When to use antiplatelet testing in clinical practice---- Jorge Saucedo(USA)
26. Carotid Bifurcation Disease - Where We Stand and Challenges for the Future? Will that be possible? ------ José Fernandes e Fernandes(Portugal)
27. International variations and trends in abdominal aortic aneurysms repair based on vascular registries-----Kevin Mani（Sweden）
28. Vasculitis for the Angiologist----Leslie Cooper(USA)
29. Upper extremity arterial disease------Leslie Cooper(USA)
30. How about TCAR and flow reversal for the brain during CAS? ------ Mahmoud Malas(USA)
31. Mechanical thromboaspiration and short duration thrombolysis for acute deep vein thrombosis---- Malay Patel (India)
32. Discoveries in real life VTE treatment form the RIETE registry----Manuel Monreal(USA)
33. Treatment of unusual location thrombosis---- Robert McBane (USA)
34. Direct oral anticoagulants in Cancer Associated thrombosis----- Robert McBane,( USA)
35. VTE prophylaxis in Japan. importance of education and mechanical prophylaxis-----Mo Makoto (Japan)
36. Neurologic complications of foam sclerotherapy VenaSeal vs RFA: 36-month results---- Nick Morrison (USA)
37. Mediterranean Diet Trial on the Prevention of Chronic Cardiovascular Diseases: a Pilot Study ------NicosAngelides（Cyprus）
38. The use of an eight-step ladder for the treatment of arterial occlusions ------Nicos Angelides（Cyprus）
39. Critical Limb Ischemia: Is open or endovascular surgery the best choice? ------Nicos Angelides（Cyprus）
40. A multifactorial approach to vascular leg ulcers--- Patrick Carpentier(France)
41. Inflammation and vascular disease and From varicose veins to VTE-----Pavel Poredos(Slovenia）
42. Clinical score for pelvic congestion syndrome----- Pier Luigi Antignani(Italy)
43. How we can reduce the incidence of post thrombotic syndrome. ----- Pier Luigi Antignani(Italy)
44. Perioperative Anticoagulation management----- Pier Luigi Antignani(Italy)
45. Risk assessment in venous thromboembolism----- Pier Luigi Antignani (Italy)
46. Recanalization during anticoagulant therapy,What is known? ----- Pier Luigi Antignani (Italy)
47. Exercise investigations in arterial claudication-----Pierre Abraham(France)
48. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism--------Prahlad Ho（Australia）
49. Different Optionsfor Surgical Treatment of Superficial Venous Systems------Roberto Simkin (Argentina)
50. New Advances inthe Treatmentof Vulvarand Pelvic Veins-----Roberto Simkin (Argentina)
51. TreatmentAestheticVeinswith Foam Usingthe Vein Viewer-----Roberto Simkin (Argentina)
52. Preclinical Atherosclerosis as marker of multifocal atherosclerosis and predictor of future cardiovascular events-----Salvatore Novo（Italy）
53. Insulin Resistance, metabolic Syndrome and Cardiovascular System Involvement-----Salvatore Novo（Italy）
54. Vascular protection by the non-vitamin K antagonist oral anticoagulants: the novelty from COMPASS-----Salvatore Novo（Italy）
55. Hemodynamics application for recurrence reduction----- Sergio Gianesini (Italy)
56. Statin the Known Unknown. How we got it wrong, good fat is essential for longevity------Sherif Sultan（Ireland）
57. Contemporary management of Aorto-iliac occlusive disease, challenges and opportunities --------Sherif Sultan（Ireland）
58. Management of Carotid patch failure, Lesson learned----------Sherif Sultan（Ireland）
59. Home therapy for critical limb ischemia and capillary bed recruitment---------Sherif Sultan（Ireland）
60. Endovascularisation or conservative therapy for intermittent claudication? ------ Thomas Karplus(Australia)
61. The new WIfI Classification in Clinical Practice: Improving limb salvage-----Tulio Navarro（Brazil）
62. Reaching aortic arch and Zone 0 with off-the-shelf devices-----Tulio Navarro（Brazil）
63. Critical Analysis of Endovascular Treatment for Thoracoabdominal Aneurysms----Tulio Navarro（Brazil）
64. Accessory saphenous vein ablation，what is there to know? -----Yongwei Ji (USA)
65. Controversies in managing superficial venous thrombosis-----Yongwei Ji(USA)
66. Vascular Ultrasound Training in Australia---Yisha Tong(Australia)
67. From 2017 ESC Guidelines to Diabetic foot care- 20years experience-----Yaozhong Zhang (Taiwan, China)
68. How to choose thereasonable method for endovascular treatment of aorto-iliac artery occlusivedisease-----Thoughts from Chinese doctors. --------Fuxian Zhang（China）
69. Management of the distal false lumen in type-B dissection------Frank Arko (USA)
70. Flex scoring catheter vessel preparation device-----Frank Arko (USA)
聯(lián)系我們會務(wù)聯(lián)系人：
劉偉龍 電話：15010258570
陳振源 電話：18501073381
李浩源 電話：18301250070
團(tuán)隊會務(wù)聯(lián)系人：
秦銀銀 電話：13811275863
學(xué)術(shù)聯(lián)系人：
郭建明 電話：13146369562
劉夢霞 電話：13681107050
趙 莉 電話: 13901264893
大會郵箱： [email protected]
信息來源：中華醫(yī)學(xué)會